C-MER Medical 2025: Dental Business Annual Revenue of HK$507 Million, Annual Patient Visits Increase by 13.9% Year-on-Year

Image Source: C-MER Eye Care Holdings Limited 2025 Annual Results Report

Dental Business 2025 Revenue: HK$507 Million / Dental Patient Visits +13.9% / Mainland China Dental Revenue: HK$460 Million

DentalGoodNews | On March 27, 2026, C-MER Eye Care Holdings Limited released its 2025 annual results report. The company achieved revenue of HK$1.947 billion in 2025 (a year-on-year increase of 1.80%); the profit for the year attributable to equity holders of the company (Net Profit Attributable to Shareholders of the Parent Company) was HK$100 million (compared to a loss of HK$135 million in the same period of 2024), achieving a turnaround to profitability year-on-year.

After excluding the impact of non-cash impairment and initial operation businesses, the adjusted profit for the year attributable to equity holders reached HK$138 million, a year-on-year increase of 81.5%. The company noted in the report that in 2025, it improved profitability by optimizing its service network and enhancing operational efficiency. Net cash generated from operating activities during the period was HK$283 million, maintaining a robust level.

Image Source: C-MER Eye Care Holdings Limited 2025 Annual Results Report

Regarding the dental business, revenue in 2025 was HK$507 million, remaining largely flat compared to the previous year. Within this, the Mainland China dental business is primarily carried by Shenzhen Aikangjian Oral Group, achieving total revenue of HK$460 million by the end of the period, a slight decrease of 1.0% year-on-year. The company continued to expand its service network in Shenzhen's Luohu, Futian, and Liantang Port areas, with the new clinic at Futian Port commencing operations in the third quarter of 2025. According to a previous report by DGN, Shenzhen Aikangjian Oral Hospital accounted for as high as 77.2% of the claimed amount under the "Pilot Scheme on Elderly Health Care Voucher Greater Bay Area," demonstrating its competitive advantage in the cross-border healthcare market.

Image Source: C-MER Eye Care Holdings Limited 2025 Annual Results Report

Meanwhile, the segment profit for the Mainland China dental business decreased from HK$96.1 million to HK$67.5 million, mainly affected by the ramp-up period of new clinics. The gross profit margin and adjusted gross profit margin for the Mainland China dental business segment decreased from 36.6% and 36.6% in 2024 to 31.7% and 31.7% in 2025, respectively, primarily due to a decrease in revenue per dental chair at Shenzhen Aikangjian.

Image Source: C-MER Eye Care Holdings Limited 2025 Annual Results Report

Structurally, the company's dental business saw a year-on-year increase of 13.9% in annual patient visits, and the number of dental chairs grew by 25.1%. However, patient visits per chair and revenue per chair decreased by 8.9% and 20.2%, respectively.

Image Source: C-MER Eye Care Holdings Limited 2025 Annual Results Report

Furthermore, Hong Kong healthcare business revenue increased by 5.2% year-on-year to HK$949 million, raising its proportion to 48.8%; Mainland China healthcare business revenue decreased by 1.3% year-on-year to HK$998 million, with its proportion falling to 51.2%. Based on the improved performance, the Board recommended the payment of a final dividend of HK 2.0 cents per share and a special dividend of HK 1.0 cent per share for 2025.